GlassScriptPhysician profile
Jacinta Madu
NPI 1497357578
$4,189.08
in general payments reported to CMS, 2019-2025
19 companies · $1,378 in 2025
The $1,378 reported for 2025 was more than what 86% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $780 · 2022: $1,048 · 2023: $623 · 2024: $359 · 2025: $1,378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,361.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,285.42 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $649.66 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $622.46 | 2025 | Cobenfy |
| Otsuka America Pharmaceutical, INC. | $399.14 | 2021-2024 | Rexulti |
| Supernus Pharmaceuticals, INC. | $252.91 | 2022-2025 | Qelbree |
| Alkermes, INC. | $167.55 | 2021-2025 | Lybalvi |
| Sunovion Pharmaceuticals INC. | $135.30 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $132.84 | 2021-2023 | Trintellix |
| Braeburn INC. | $124.40 | 2025 | Brixadi |
| Mylan Specialty L.P. | $122.08 | 2024 | Yupelri |
| Neurocrine Biosciences, INC. | $100.97 | 2024 | |
| Bausch Health US, LLC | $49.77 | 2021-2022 | |
| Corium, LLC | $38.75 | 2022 | |
| Avanir Pharmaceuticals, INC. | $32.97 | 2021 | |
| Almatica Pharma LLC | $20.74 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $14.27 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $13.89 | 2021 | |
| Adlon Therapeutics L.P. | $13.88 | 2021 | |
| Eisai INC. | $12.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacinta Madu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.